Injectable Drug Delivery Devices Market Size

Injectable Drug Delivery Devices Market size was over USD 115.03 billion in 2023 and is anticipated to reach USD 280.59 billion by the end of 2036, growing at around 7.1% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of injectable drug delivery devices is assessed at USD 121.56 billion.

The growth of the global injectable drug delivery device market can be attributed to the increasing implementation of biologics, growing prevalence of chronic disorders, escalating incidence of needlestick injuries, and other benefits of injections. Factors such as safety syringes, prefilled syringes, auto-injectors, and others, have increased the demand for injectable drug delivery devices. Moreover, increasing prevalence of chronic diseases, such as, cardiovascular disease, cancer, auto-immune disease and diabetes, is expected to drive the demand for such devices. According to the report by the WHO, 422 million people have diabetes on a global level, and 1.6 million deaths are directly attributed to diabetes each year. Moreover, Cardiovascular diseases (CVD) are currently the leading cause of deaths and disability worldwide causing around 17.9 million deaths globally. The need for self-injections in homecare settings without the requirement of any professional help for the treatment of these diseases is estimated to act as a major growth driver for the market.